Literature DB >> 30606759

Acquired Expression of Mutant Mitofusin 2 Causes Progressive Neurodegeneration and Abnormal Behavior.

Kaori Ishikawa1,2, Satoshi Yamamoto3, Satoko Hattori4, Naoya Nishimura3, Haruna Tani2, Takayuki Mito5, Hirokazu Matsumoto3, Tsuyoshi Miyakawa4, Kazuto Nakada1,2.   

Abstract

Neurons have high plasticity in developmental and juvenile stages that decreases in adulthood. Mitochondrial dynamics are highly important in neurons to maintain normal function. To compare dependency on mitochondrial dynamics in juvenile and adult stages, we generated a mouse model capable of selective timing of the expression of a mutant of the mitochondrial fusion factor Mitofusin 2 (MFN2). Mutant expression in the juvenile stage had lethal effects. Contrastingly, abnormalities did not manifest until 150 d after mutant expression during adulthood. After this silent 150 d period, progressive neurodegeneration, abnormal behaviors, and learning and memory deficits similar to those seen in human neurodegenerative diseases were observed. This indicates that abnormal neuronal mitochondrial dynamics seriously affect survival during early life stages and can also significantly damage brain function after maturation. Our findings highlight the need to consider the timing of disease onset in mimicking human neurodegenerative diseases.SIGNIFICANCE STATEMENT To compare the dependency on mitochondrial dynamics in neurons in juvenile and adult stages, we generated a mouse model expressing a mutant of the mitochondrial fusion factor MFN2 in an arbitrary timing. Juvenile expression of the mutant showed acute and severe phenotypes and had lethal effects; however, post-adult expression induced delayed but progressive phenotypes resembling those found in human neurodegenerative diseases. Our results indicate that abnormal neuronal mitochondrial dynamics seriously affect survival during early life stages and can also significantly damage brain function after maturation. This strongly suggests that the timing of expression should be considered when establishing an animal model that closely resembles human neurodegenerative diseases.
Copyright © 2019 the authors 0270-6474/19/391588-17$15.00/0.

Entities:  

Keywords:  MFN2; cognitive impairment; hyperactivity; mitochondrial dynamics; progressive neurodegeneration

Year:  2019        PMID: 30606759      PMCID: PMC6391572          DOI: 10.1523/JNEUROSCI.2139-18.2018

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  38 in total

1.  Inter-mitochondrial complementation: Mitochondria-specific system preventing mice from expression of disease phenotypes by mutant mtDNA.

Authors:  K Nakada; K Inoue; T Ono; K Isobe; A Ogura; Y I Goto; I Nonaka; J I Hayashi
Journal:  Nat Med       Date:  2001-08       Impact factor: 53.440

2.  Transgenic mice with Alzheimer presenilin 1 mutations show accelerated neurodegeneration without amyloid plaque formation.

Authors:  D H Chui; H Tanahashi; K Ozawa; S Ikeda; F Checler; O Ueda; H Suzuki; W Araki; H Inoue; K Shirotani; K Takahashi; F Gallyas; T Tabira
Journal:  Nat Med       Date:  1999-05       Impact factor: 53.440

3.  Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophrenia.

Authors:  Tsuyoshi Miyakawa; Lorene M Leiter; David J Gerber; Raul R Gainetdinov; Tatyana D Sotnikova; Hongkui Zeng; Marc G Caron; Susumu Tonegawa
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-08       Impact factor: 11.205

4.  Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A.

Authors:  Stephan Züchner; Irina V Mersiyanova; Maria Muglia; Nisrine Bissar-Tadmouri; Julie Rochelle; Elena L Dadali; Mario Zappia; Eva Nelis; Alessandra Patitucci; Jan Senderek; Yesim Parman; Oleg Evgrafov; Peter De Jonghe; Yuji Takahashi; Shoij Tsuji; Margaret A Pericak-Vance; Aldo Quattrone; Esra Battaloglu; Alexander V Polyakov; Vincent Timmerman; J Michael Schröder; Jeffery M Vance; Esra Battologlu
Journal:  Nat Genet       Date:  2004-04-04       Impact factor: 38.330

Review 5.  Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. A review.

Authors:  D Allan Butterfield
Journal:  Free Radic Res       Date:  2002-12

Review 6.  Mitochondrial diseases in man and mouse.

Authors:  D C Wallace
Journal:  Science       Date:  1999-03-05       Impact factor: 47.728

Review 7.  PET imaging of amyloid in Alzheimer's disease.

Authors:  Agneta Nordberg
Journal:  Lancet Neurol       Date:  2004-09       Impact factor: 44.182

8.  Accumulation of pathogenic DeltamtDNA induced deafness but not diabetic phenotypes in mito-mice.

Authors:  Kazuto Nakada; Akitsugu Sato; Hideyuki Sone; Atsuko Kasahara; Katsuhisa Ikeda; Yasuo Kagawa; Hiromichi Yonekawa; Jun-Ichi Hayashi
Journal:  Biochem Biophys Res Commun       Date:  2004-10-08       Impact factor: 3.575

9.  Decreased locomotor activity in mice expressing tTA under control of the CaMKII alpha promoter.

Authors:  B C McKinney; J S Schneider; G L Schafer; J L Lowing; S Mohan; M X Zhao; M Y Heng; R L Albin; A F Seasholtz; H Akil; G G Murphy
Journal:  Genes Brain Behav       Date:  2007-07-19       Impact factor: 3.449

10.  Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic development.

Authors:  Hsiuchen Chen; Scott A Detmer; Andrew J Ewald; Erik E Griffin; Scott E Fraser; David C Chan
Journal:  J Cell Biol       Date:  2003-01-13       Impact factor: 10.539

View more
  3 in total

1.  Mitochondrial ubiquitin ligase alleviates Alzheimer's disease pathology via blocking the toxic amyloid-β oligomer generation.

Authors:  Keisuke Takeda; Aoi Uda; Mikihiro Mitsubori; Shun Nagashima; Hiroko Iwasaki; Naoki Ito; Isshin Shiiba; Satoshi Ishido; Masaaki Matsuoka; Ryoko Inatome; Shigeru Yanagi
Journal:  Commun Biol       Date:  2021-02-12

2.  Age-Dependent Behavioral and Metabolic Assessment of App NL-G-F/NL-G-F Knock-in (KI) Mice.

Authors:  Shanshan Wang; Taiga Ichinomiya; Paul Savchenko; Swetha Devulapalli; Dongsheng Wang; Gianna Beltz; Takashi Saito; Takaomi C Saido; Steve L Wagner; Hemal H Patel; Brian P Head
Journal:  Front Mol Neurosci       Date:  2022-07-29       Impact factor: 6.261

Review 3.  Mitochondrial protein dysfunction in pathogenesis of neurological diseases.

Authors:  Liang Wang; Ziyun Yang; Xiumei He; Shiming Pu; Cheng Yang; Qiong Wu; Zuping Zhou; Xiaobo Cen; Hongxia Zhao
Journal:  Front Mol Neurosci       Date:  2022-09-07       Impact factor: 6.261

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.